Schedule 13G ownership disclosure
VITAE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 92847N103
Event date: 2012-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,174,315
- Percent of class
- 6.5200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-009385
- Form type
- SC 13G
- Filer
- ATLAS VENTURE FUND VI LP
- CIK
- CIK 1136148
- Filed
- Feb 12, 2015
- Reporting period
- Dec 31, 2012
- Description
- Schedule 13G beneficial ownership